MOH — authorised 15 August 1994
- Marketing authorisation holder: MYLAN
- Status: likely_approved
MOH authorised Cystagon on 15 August 1994
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 15 August 1994.
MYLAN holds the Israeli marketing authorisation.